Baxter International Inc. (BAX) News

Baxter International Inc. (BAX): $73.23

0.63 (+0.87%)

POWR Rating

Component Grades













Filter BAX News Items

BAX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BAX News Highlights

  • BAX's 30 day story count now stands at 35.
  • Over the past 16 days, the trend for BAX's stories per day has been choppy and unclear. It has oscillated between 1 and 8.
  • MA, DRUG and AMN are the most mentioned tickers in articles about BAX.

Latest BAX News From Around the Web

Below are the latest news stories about Baxter International Inc that investors may wish to consider to help them evaluate BAX as an investment opportunity.

Baxter Expands Cybersecurity Commitment, Joins Forces With U.S. Cybersecurity and Infrastructure Security Agency (CISA) Led Program

DEERFIELD, Ill., February 23, 2022--Baxter has received authorization from the Common Vulnerability and Exposures (CVE®) program to be a CVE Numbering Authority.

Yahoo | February 23, 2022

SEC fines Baxter $18M for transactions that resulted in misstatement of net income

The U.S. Securities and Exchange Commission ("SEC") has levied an $18M fine against Baxter International (NYSE:BAX) for engaging in what it describes as improper intra-company foreign exchange transactions that resulted in the misstatement of the company’s net income. In addition, the agency settled charges with Baxter's (BAX) former treasurer and...

Seeking Alpha | February 22, 2022

Baxter: A Potential Premium Upside Of 15%

Baxter International (BAX) is an appealing business. Its fundamentals of supplying medical equipment have a great correlation to society as it is today. Its expertise in several solutions is well-used by most of its customers, using Baxter to supply far more advanced products than say, cotton swabs and wound dressings....

Wolf Report on Seeking Alpha | February 22, 2022

Tuesdays Top Analyst Upgrades and Downgrades: Advanced Micro Devices, Baxter International, Constellation Energy, CrowdStrike, Datadog, Nutrien, Sandstorm Gold, SentinelOne, Zhihu and More

Tuesday''s top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Constellation Energy, CrowdStrike, Datadog, Nutrien, Sandstorm Gold, SentinelOne and Zhihu.

24/7 Wall street | February 22, 2022

U.S. SEC announces charges, penalty on medtech firm Baxter for accounting improprieties

The SEC also announced settled charges against Baxter's former treasurer and assistant treasurer, Scott Bohaboy and Jeffrey Schaible, respectively, for their misconduct related to these transactions. "From at least 1995 to 2019, Baxter used a convention to convert non-U.S. dollar denominated transactions and assets and liabilities on its financial statements that was not in accordance with U.S. GAAP or generally accepted accounting principles", the SEC said in a statement.

Yahoo | February 22, 2022

Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference

DEERFIELD, Ill., February 22, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.

Yahoo | February 22, 2022

Medtronic's (MDT) Q3 Earnings Beat, Revenues Lag Estimates

Medtronic (MDT) registers organic growth in the Cardiovascular, Neuroscience and Diabetes segments in Q3.

Yahoo | February 22, 2022

Baxter International Inc. Consensus Indicates Potential 17.1% Upside

Baxter International Inc. found using ticker (BAX) now have 16 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 110 and 88 and has a mean target at 97. Given that the stocks previous close was at 82.8 this indicates there is a potential upside of 17.1%. The 50 day MA is 85.45 and the 200 day moving average is 81.33. The company has a market capitalisation of $41,232m. Company Website: [stock_market_widget type="chart" template="basic" color="green" assets=BAX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $48,303m based on the market concensus. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare product...

DirectorsTalk | February 21, 2022

NextGen (NXGN)-Verato Tie Up to Improve Patient Insights

NextGen (NXGN) expects to deliver better insights into patient health history with its latest collaboration with Verato.

Yahoo | February 21, 2022

Shockwave Medical (SWAV) Gains 3.2% Post Q4 Earnings Beat

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and expansion in gross margin.

Yahoo | February 21, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7144 seconds.